Drugs / DC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02632188 | Sep 2015 → Mar 2017 | liver cancer | Second Military Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02632188 ↗ |
| Modality | Cell therapy | “dendritic cell-precision multiple antigen T cells” NCT02632188 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT02632188 ↗ |